Display options
Cite
Vogt J, Beyer F, Sistermanns J, et al. Symptom Burden and Palliative Care Needs of Patients with Incurable Cancer at Diagnosis and During the Disease Course. Oncologist. 2021;26(6):e1058-e1065doi: 10.1002/onco.13751.
Vogt, J., Beyer, F., Sistermanns, J., Kuon, J., Kahl, C., Alt-Epping, B., Stevens, S., Ahlborn, M., George, C., Heider, A., Tienken, M., Loquai, C., Stahlhut, K., Ruellan, A., Kubin, T., Dietz, A., Oechsle, K., Mehnert-Theuerkauf, A., van Oorschot, B., Thomas, M., Ortmann, O., Engel, C., Lordick, F. (2021). Symptom Burden and Palliative Care Needs of Patients with Incurable Cancer at Diagnosis and During the Disease Course. The oncologist, 26(6), e1058-e1065. https://doi.org/10.1002/onco.13751
Vogt, Jeannette, et al. "Symptom Burden and Palliative Care Needs of Patients with Incurable Cancer at Diagnosis and During the Disease Course." The oncologist vol. 26,6 (2021): e1058-e1065. doi: https://doi.org/10.1002/onco.13751
Vogt J, Beyer F, Sistermanns J, Kuon J, Kahl C, Alt-Epping B, Stevens S, Ahlborn M, George C, Heider A, Tienken M, Loquai C, Stahlhut K, Ruellan A, Kubin T, Dietz A, Oechsle K, Mehnert-Theuerkauf A, van Oorschot B, Thomas M, Ortmann O, Engel C, Lordick F. Symptom Burden and Palliative Care Needs of Patients with Incurable Cancer at Diagnosis and During the Disease Course. Oncologist. 2021 Jun;26(6):e1058-e1065. doi: 10.1002/onco.13751. Epub 2021 Mar 30. PMID: 33687742; PMCID: PMC8176980.
Copy Download .nbib Format: NLM
Share it on

Oncologist. 2021 Jun;26(6):e1058-e1065. doi: 10.1002/onco.13751. Epub 2021 Mar 30.

Symptom Burden and Palliative Care Needs of Patients with Incurable Cancer at Diagnosis and During the Disease Course.

The oncologist

Jeannette Vogt, Franziska Beyer, Jochen Sistermanns, Jonas Kuon, Christoph Kahl, Bernd Alt-Epping, Susanne Stevens, Miriam Ahlborn, Christian George, Andrea Heider, Maria Tienken, Carmen Loquai, Kerstin Stahlhut, Anne Ruellan, Thomas Kubin, Andreas Dietz, Karin Oechsle, Anja Mehnert-Theuerkauf, Birgitt van Oorschot, Michael Thomas, Olaf Ortmann, Christoph Engel, Florian Lordick,

Affiliations

  1. Leipzig University Medical Center, University Cancer Center Leipzig, Leipzig, Germany.
  2. Department of Radiation Oncology, Kliniken Maria Hilf, Mönchengladbach, Germany.
  3. Department of Thoracic Oncology, Translational Lung Research Center Heidelberg TLRC-H, Thoraxklinik at Heidelberg University Hospital, Member of the German Center for Lung Research DZL, Heidelberg, Germany.
  4. Department of Hematology, Oncology and Palliative Care, Klinikum Magdeburg, Magdeburg, Germany.
  5. Department of Palliative Medicine, University Hospital Heidelberg, Heidelberg, Germany.
  6. Department of Palliative Medicine, University Medical Center Göttingen, Göttingen, Germany.
  7. Department of Medical Oncology, Kliniken Essen Mitte, Essen, Germany.
  8. Department of Oncology and Hematology, Klinikum Braunschweig, Braunschweig, Germany.
  9. Department of Gynecology, Klinikum Südstadt Rostock, Rostock, Germany.
  10. 3rd Department of Medicine, Klinikum Leverkusen, Leverkusen, Germany.
  11. Skin Cancer Center Rhein-Main, University Medical Center Mainz, Mainz, Germany.
  12. Hematology Oncology and Palliative Care Clinic, Immanuel Klinik und Poliklinik Rüdersdorf, Rüdersdorf, Berlin, Germany.
  13. Department of Hematology, Oncology and Palliative Care, Städtisches Klinikum Karlsruhe, Karlsruhe, Germany.
  14. Department of Hematology, Oncology and Palliative Care, Klinikum Traunstein, Traunstein, Germany.
  15. ENT Department, Leipzig University Medical Center, Leipzig, Germany.
  16. Department of Oncology and Hematology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  17. Department of Medical Psychology and Medical Sociology, Leipzig University Medical Center, Leipzig, Germany.
  18. Interdisciplinary Department of Palliative Medicine, University Hospital Würzburg, Würzburg, Germany.
  19. Department for Gynecology and Obstetrics, University of Regensburg, Caritas Hospital St. Josef, Regensburg, Germany.
  20. Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Leipzig, Germany.

PMID: 33687742 PMCID: PMC8176980 DOI: 10.1002/onco.13751

Abstract

BACKGROUND: Although current guidelines advocate early integration of palliative care, symptom burden and palliative care needs of patients at diagnosis of incurable cancer and along the disease trajectory are understudied.

MATERIAL AND METHODS: We assessed distress, symptom burden, quality of life, and supportive care needs in patients with newly diagnosed incurable cancer in a prospective longitudinal observational multicenter study. Patients were evaluated using validated self-report measures (National Comprehensive Cancer Network Distress Thermometer [DT], Functional Assessment of Cancer Therapy [FACT], Schedule for the Evaluation of Individual Quality of Life [SEIQoL-Q], Patients Health Questionnaire-4 [PHQ-4], modified Supportive Care Needs Survey [SCNS-SF-34]) at baseline (T0) and at 3 (T1), 6 (T2), and 12 months (T3) follow-up.

RESULTS: From October 2014 to October 2016, 500 patients (219 women, 281 men; mean age 64.2 years) were recruited at 20 study sites in Germany following diagnosis of incurable metastatic, locally advanced, or recurrent lung (217), gastrointestinal (156), head and neck (55), gynecological (57), and skin (15) cancer. Patients reported significant distress (DT score ≥ 5) after diagnosis, which significantly decreased over time (T0: 67.2%, T1: 51.7%, T2: 47.9%, T3: 48.7%). The spectrum of reported symptoms was broad, with considerable variety between and within the cancer groups. Anxiety and depressiveness were most prevalent early in the disease course (T0: 30.8%, T1: 20.1%, T2: 14.7%, T3: 16.9%). The number of patients reporting unmet supportive care needs decreased over time (T0: 71.8 %, T1: 61.6%, T2: 58.1%, T3: 55.3%).

CONCLUSION: Our study confirms a variable and mostly high symptom burden at the time of diagnosis of incurable cancer, suggesting early screening by using standardized tools and underlining the usefulness of early palliative care.

IMPLICATIONS FOR PRACTICE: A better understanding of symptom burden and palliative care needs of patients with newly diagnosed incurable cancer may guide clinical practice and help to improve the quality of palliative care services. The results of this study provide important information for establishing palliative care programs and related guidelines. Distress, symptom burden, and the need for support vary and are often high at the time of diagnosis. These findings underscore the need for implementation of symptom screening as well as early palliative care services, starting at the time of diagnosis of incurable cancer and tailored according to patients' needs.

© 2021 The Authors. The Oncologist published by Wiley Periodicals LLC on behalf of AlphaMed Press.

Keywords: Cancer; Distress; Palliative care; Quality of life; Symptom burden

References

  1. Oncol Nurs Forum. 2017 May 01;44(3):329-336 - PubMed
  2. Support Care Cancer. 2012 Oct;20(10):2415-24 - PubMed
  3. J Pain Symptom Manage. 2019 Aug;58(2):235-243.e1 - PubMed
  4. J Pain Symptom Manage. 2020 Jan;59(1):39-48 - PubMed
  5. Qual Life Res. 2014 Sep;23(7):2025-30 - PubMed
  6. N Engl J Med. 2010 Aug 19;363(8):733-42 - PubMed
  7. J Clin Oncol. 2010 Jun 20;28(18):3084-9 - PubMed
  8. Gynecol Oncol. 2014 Nov;135(2):249-54 - PubMed
  9. Cochrane Database Syst Rev. 2017 Jun 12;6:CD011129 - PubMed
  10. BMC Palliat Care. 2018 Jul 23;17(1):96 - PubMed
  11. J Natl Compr Canc Netw. 2014 Dec;12(12):1763-71; quiz 1771 - PubMed
  12. Ann Oncol. 2018 Jan 1;29(1):36-43 - PubMed
  13. JAMA. 2009 Aug 19;302(7):741-9 - PubMed
  14. J Clin Oncol. 2015 May 1;33(13):1438-45 - PubMed
  15. Support Care Cancer. 2012 Jul;20(7):1377-94 - PubMed
  16. Oncologist. 2019 Aug;24(8):1121-1127 - PubMed
  17. N Engl J Med. 2012 Apr 5;366(14):1310-8 - PubMed
  18. Psychosomatics. 2009 Nov-Dec;50(6):613-21 - PubMed
  19. Prostate Cancer Prostatic Dis. 2008;11(4):390-6 - PubMed
  20. BMC Palliat Care. 2019 Jun 25;18(1):51 - PubMed
  21. Eur J Cancer. 2016 Sep;65:61-8 - PubMed
  22. Psychooncology. 2013 Feb;22(2):388-95 - PubMed
  23. Am J Hosp Palliat Care. 2021 Jan;38(1):62-67 - PubMed
  24. J Clin Oncol. 1999 Nov;17(11):3603-11 - PubMed
  25. Cancer. 2014 Sep 15;120(18):2902-9 - PubMed
  26. Lancet Oncol. 2018 Mar;19(3):394-404 - PubMed
  27. Eur J Cancer Care (Engl). 2018 Jan;27(1): - PubMed
  28. J Clin Oncol. 2017 Mar 10;35(8):834-841 - PubMed
  29. J Clin Oncol. 2017 Jan;35(1):96-112 - PubMed
  30. Acta Oncol. 2011 Jun;50(5):648-52 - PubMed
  31. Cancer. 2012 Feb 1;118(3):856-63 - PubMed
  32. Lancet. 2014 May 17;383(9930):1721-30 - PubMed
  33. Ann Palliat Med. 2015 Jul;4(3):99-121 - PubMed
  34. Oncol Res Treat. 2016;39(4):186-91 - PubMed
  35. Dtsch Arztebl Int. 2020 Feb 14;116(7):108-115 - PubMed
  36. J Palliat Med. 2010 Oct;13(10):1273-6 - PubMed
  37. J Affect Disord. 2010 Apr;122(1-2):86-95 - PubMed
  38. Eval Health Prof. 2005 Jun;28(2):192-211 - PubMed
  39. J Clin Oncol. 1993 Mar;11(3):570-9 - PubMed
  40. Health Qual Life Outcomes. 2003 Dec 16;1:79 - PubMed
  41. J Geriatr Oncol. 2020 Jul;11(6):969-975 - PubMed
  42. Clin Med Insights Oncol. 2019 Feb 14;13:1179554919829500 - PubMed

MeSH terms

Publication Types